Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Antiviral Research|July 2, 2015
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intentRobert G Gish, Man-Fung Yuen, Henry Lik Yuen Chan, et al.
Nucleic Acids Research|February 10, 2017
Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analysesVladimir S Trubetskoy, Jacob B Griffin, Anthony L Nicholas, et al.
Plos Computational Biology|March 6, 2007
PPARalpha siRNA-treated expression profiles uncover the causal sufficiency network for compound-induced liver hypertrophyXudong Dai, Angus T De Souza, Hongyue Dai, et al.
The Journal of Pediatrics|March 6, 2009
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled studyFriedrich K Trefz, Barbara K Burton, Nicola Longo, et al.
Molecular Cancer Therapeutics|October 29, 2017
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell CarcinomaSo C Wong, Weijun Cheng, Holly Hamilton, et al.
Science Translational Medicine|September 29, 2017
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAgChristine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2013
Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infectionChristine I Wooddell, David B Rozema, Markus Hossbach, et al.
JCI Insight|May 8, 2020
Development of an RNAi therapeutic for alpha-1-antitrypsin liver diseaseChristine I Wooddell, Keith Blomenkamp, Ryan M Peterson, et al.
Pageof 7